News from aidsmap

Use of generic versions of direct-acting antivirals resulted
in very high cure rates for people who obtained the products through three
buyers’ clubs, indicating that the generic products are effective, according
to three ...

There is a naivety among many HIV prevention researchers and
advocates about the steps needed to introduce and implement new HIV prevention
technologies such as oral pre-exposure prophylaxis (PrEP), vaginal rings and ...

Results from the MTN-017 study of 1% tenofovir gel as a
rectal microbicide were presented to the Conference on Retroviruses and Opportunistic Infections (CROI 2016) on Wednesday. The
study compares the safety ...

There is evidence that some groups of Australian and
American gay men are considering HIV-positive partners’ undetectable viral load
and the time elapsed since an HIV-negative partner last tested when making
decisions about ...

The reasons whether or not
people come forward for pre-exposure prophylaxis (PrEP) or take it once
prescribed are likely to be very mixed, and dependent as much on local
political and cultural beliefs ...

For some people in some settings, less frequent pre-exposure prophylaxis (PrEP)
regimens with doses linked to sexual activity are feasible, with high numbers
of sexual acts protected by PrEP, studies that were ...

A reduced
tenofovir (Viread) dose of 150mg
daily appears to be a safe and effective treatment for people with HIV who have moderate renal impairment, investigators from Thailand report in the
online edition ...

UNAIDS 2012 Progress Report

UNAIDS Statistics

HIV Prevalence: 1.3%

530 000 people living with HIV

28 000 deaths from AIDS in 2009

aidsmap subscribers

There are 476 registered aidsmap users in Thailand

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends
checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member
of your healthcare team for advice tailored to your situation.